期刊文献+

表皮生长因子受体在涎腺腺样囊性癌中的表达及其在肿瘤侵袭中的作用 被引量:4

Expression of epidermal growth factor receptor in salivary adenoid cystic carcinoma and its role in cancer invasion
原文传递
导出
摘要 目的研究表皮生长因子受体(EGFR)在涎腺腺样囊性癌(SACC)中的表达,探讨EGFR的表达与SACC临床病理特征的关系及其在肿瘤侵袭中的作用。方法收集54例SACC患者的临床病理资料,采用免疫组化sP法检测EGFR在SACC组织中的表达,分析EGFR表达与SACC临床病理特征的关系。结果EGFR在SACC组织中的表达主要分布于细胞膜和细胞浆中。在54例SACC患者中,EGFR的阳性表达率为75.9%;而在正常涎腺组织中,EGFR表达不明显或仅在腺管周围的腺泡细胞内微量表达,阳性表达率为10.0%,两组比较差异有统计学意义(P〈0.05)。EGFR的表达与SACC的T分期、组织学类型、远处转移、淋巴结转移、神经侵犯有关(均P〈0.05)。结论EGFR在胞浆中的高水平表达可能在侵袭癌的进展中发挥重要作用,对其深入研究有望为腺样囊性癌的治疗带来新的策略。 Objective To assess the epidermal growth factor receptor (EGFR) status in salivary adenoid cystic carcinoma and explore its role in cancer invasion. Methods Fifty-four patients with pathologically confirmed salivary adenoid cystic carcinoma (SACC) were divided into invasion group and non-invasion group. The EGFR expression was determined by immunohistochemstry (SP staining). The relations between the EGFR expression and the SACC clinical pathological characteristics were analyzed. Results EGFR were mainly expressed in the cell membrane and cytoplasm in the tissue of SACC. The positive rate of EGFR expression in the tumor tissue was 75.9% (41/54), and EGFR was over-expressed in the cytoplasm. The positive rate of EGFR expression in invasion group was higher than that in the non- invasion group ( 10.0% , P 〈 O. 05 ). EGFR expression were related with the SACC T stages, histological types, distant metastasis, lymph node metastasis, and nerve invasion (P 〈 0. 05). Conclusions A higher expression of EGFR gene in the cytoplasm may have important effect on the progression of invasive carcinoma. Further investigations are required to develop new strategy in the treatment of salivary adenoid cystic carcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2012年第4期278-280,共3页 Chinese Journal of Oncology
基金 浙江省卫生高层次创新人才培养工程基金 浙江省科技计划项目(2009C33116)
关键词 涎腺 腺样囊性 受体 表皮生长因子 免疫组织化学 肿瘤侵润 Salivary glands Carcinoma, adenoid cystic Receptor, epidermal growthfactor Immunohistochemistry Neoplasms invasiveness
  • 相关文献

参考文献17

  • 1Laurie SA,Ho AL,Fury MG. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands:a systematic review[J].Lancet Oncology,2011.815-824.doi:10.1016/S1470-2045(10)70245-X.
  • 2Banett AW,Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands:a valid prognostic indicator[J].Oral Oncology,2009.936-940.
  • 3Hardy S,Julien SG,Tremblay ML. Impact of oncogenic protein tyrosine phosphatases in cancer[J].Anticancer Agents Med Chem,2012.4-18.doi:10.2174/187152012798764741.
  • 4Gotoh N. Somatic mutations of the EGF receptor and their signal transducers affect the efficacy of EGF receptor-specific tyrosine kinase inhibitors[J].Int J Clin Exp Pathol,2011.403-409.
  • 5Segatto O,Anastasi S,Alema S. Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors[J].Journal of Cell Science,2011.1785-1793.doi:10.1242/jcs.083303.
  • 6Bartholomeusz C,Yamasski F,Saso H. Gemcitabine overoomes erlotinib resistance in EGFR-overexpressing cancer cells through downregulation of Akt[J].Cancer,2011.435-442.
  • 7Malapelle U,Bellevicine C,Zeppa P. Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy:a review[J].Diagnostic Cytopathology,2011.703-710.
  • 8Janku F,Garrido-Laguna I,Petruzelka LB. Novel therapeutic targets in non-small cell lung cancer[J].JOURNAL OF THORACIC ONCOLOGY,2011.1601-1612.doi:10.1097/JTO.0b013e31822944b3.
  • 9Howe LR,Brown PH. Targeting the HER/EGFR/ErbB family to prevent breast cancer[J].Cancer Prev Res (Phila),2011.1149-1157.doi:10.1158/1940-6207.CAPR-11-0334.
  • 10Naik DS,Sharma S,Ray A. Epidermal growth factor receptor expression in urinary bladder cancer[J].INDIAN JOURNAL OF UROLOGY,2011.208-214.

同被引文献162

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部